Regeneron Pharmaceuticals

CUSIP: 75886f107 Class: COM

JOHN G ULLMAN & ASSOCIATES INC's Holding History (CIK: 0000919530)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,830 Value ($000) $1,413 Avg Close Range
Q3 2025
Shares 1,955 Value ($000) $1,099 Avg Close Range
Q2 2025
Shares 1,405 Value ($000) $738 Avg Close Range
Q1 2025
Shares 6,430 Value ($000) $4,078 Avg Close Range
Q4 2024
Shares 3,315 Value ($000) $2,361 Avg Close Range
Q4 2022
Shares 4,260 Value ($000) $3 Avg Close Range
Q3 2022
Shares 4,390 Value ($000) $3,024 Avg Close Range
Q2 2022
Shares 4,450 Value ($000) $2,631 Avg Close Range
Q1 2022
Shares 800 Value ($000) $559 Avg Close Range
Q4 2021
Shares 800 Value ($000) $505 Avg Close Range
Q3 2021
Shares 800 Value ($000) $484 Avg Close Range
Q2 2021
Shares 800 Value ($000) $447 Avg Close Range
Q1 2021
Shares 800 Value ($000) $379 Avg Close Range
Q4 2020
Shares 800 Value ($000) $386 Avg Close Range
Q3 2020
Shares 800 Value ($000) $448 Avg Close Range
Q2 2020
Shares 800 Value ($000) $499 Avg Close Range
Q1 2020
Shares 800 Value ($000) $391 Avg Close Range
Q4 2019
Shares 800 Value ($000) $300 Avg Close Range
Q3 2019
Shares 825 Value ($000) $229 Avg Close Range
Q2 2019
Shares 900 Value ($000) $282 Avg Close Range
Q1 2019
Shares 900 Value ($000) $370 Avg Close Range
Q4 2018
Shares 900 Value ($000) $336 Avg Close Range